相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy
Ren Jie Phang et al.
CARDIOVASCULAR RESEARCH (2023)
miR-486 attenuates cardiac ischemia/reperfusion injury and mediates the beneficial effect of exercise for myocardial protection
Yihua Bei et al.
MOLECULAR THERAPY (2022)
MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes
Shawn Veitch et al.
CARDIOVASCULAR DIABETOLOGY (2022)
Small Extracellular Vesicles From Brown Adipose Tissue Mediate Exercise Cardioprotection
Hang Zhao et al.
CIRCULATION RESEARCH (2022)
Exercise attenuates angiotensinII-induced muscle atrophy by targeting PPARy/miR-29b
Qi Liu et al.
JOURNAL OF SPORT AND HEALTH SCIENCE (2022)
Mir-30d Regulates Cardiac Remodeling by Intracellular and Paracrine Signaling
Jin Li et al.
CIRCULATION RESEARCH (2021)
MicroRNA-151 Attenuates Apoptosis of Endothelial Cells Induced by Oxidized Low-density Lipoprotein by Targeting Interleukin-17A (IL-17A)
Fanfeng Chen et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2021)
Inhibition of lncRNA MAAT Controls Multiple Types of Muscle Atrophy by cis- and trans-Regulatory Actions
Jin Li et al.
MOLECULAR THERAPY (2021)
miR-30d-5p suppresses proliferation and autophagy by targeting ATG5 in renal cell carcinoma
Liang Liang et al.
FEBS OPEN BIO (2021)
Angiotensin II-induced muscle atrophy via PPARγ suppression is mediated by miR-29b
Jin Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
被撤回的出版物: Knockdown EZH2 attenuates cerebral ischemia-reperfusion injury via regulating microRNA-30d-3p methylation and USP22 (Retracted article. See vol. 188, pg. 38, 2022)
Dianshi Jin et al.
BRAIN RESEARCH BULLETIN (2021)
Plasma Exosome-Enriched Extracellular Vesicles From Lactating Mothers With Type 1 Diabetes Contain Aberrant Levels of miRNAs During the Postpartum Period
Caroline Frorup et al.
FRONTIERS IN IMMUNOLOGY (2021)
Serum microRNA-30d is a sensitive biomarker for angiotensin II-induced cardiovascular complications in rats
Masaki Morishima et al.
HEART AND VESSELS (2021)
Elevated EZH2 in ischemic heart disease epigenetically mediates suppression of NaV1.5 expression
Limei Zhao et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)
Dickkopf 3: a Novel Target Gene of miR-25-3p in Promoting Fibrosis-Related Gene Expression in Myocardial Fibrosis
Ni Zeng et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2021)
MicroRNA-30 regulates left ventricular hypertrophy in chronic kidney disease
Jingfu Bao et al.
JCI INSIGHT (2021)
Expression Profile of Circulating MicroRNAs in Dogs With Cardiac Hypertrophy: A Pilot Study
Woong-Bin Ro et al.
FRONTIERS IN VETERINARY SCIENCE (2021)
Preclinical trial of a MAP4K4 inhibitor to reduce infarct size in the pig: does cardioprotection in human stem cell-derived myocytes predict success in large mammals?
Maaike te Lintel Hekkert et al.
BASIC RESEARCH IN CARDIOLOGY (2021)
Percutaneous Intracoronary Delivery of Plasma Extracellular Vesicles Protects the Myocardium Against Ischemia-Reperfusion Injury in Canis
Hongyun Wang et al.
HYPERTENSION (2021)
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study
Jorg Taubel et al.
EUROPEAN HEART JOURNAL (2021)
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study
Jorg Taubel et al.
EUROPEAN HEART JOURNAL (2021)
The roles of microRNA in redox metabolism and exercise-mediated adaptation
Ferenc Torma et al.
JOURNAL OF SPORT AND HEALTH SCIENCE (2020)
FBXW7 promotes pathological cardiac hypertrophy by targeting EZH2-SIX1 signaling
Weinian Gao et al.
EXPERIMENTAL CELL RESEARCH (2020)
Inhibition of EZH2 attenuates coronary heart disease by interacting with microRNA-22 to regulate the TXNIP/nuclear factor-κB pathway
Yong Liu et al.
EXPERIMENTAL PHYSIOLOGY (2020)
Efficiency and Target Derepression of Anti-miR-92a: Results of a First in Human Study
Wesley Tyler Abplanalp et al.
NUCLEIC ACID THERAPEUTICS (2020)
Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4
Pelin A. Golforoush et al.
SCIENTIFIC REPORTS (2020)
The anti-microbial peptide LL-37/CRAMP levels are associated with acute heart failure and can attenuate cardiac dysfunction in multiple preclinical models of heart failure
Qiulian Zhou et al.
THERANOSTICS (2020)
EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer
Huilong Yin et al.
THERANOSTICS (2020)
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo
Lorna R. Fiedler et al.
CELL STEM CELL (2019)
GRP78 (Glucose-Regulated Protein of 78 kDa) Promotes Cardiomyocyte Growth Through Activation of GATA4 (GATA-Binding Protein 4)
Guangyu Zhang et al.
HYPERTENSION (2019)
RNA-based diagnostic and therapeutic strategies for cardiovascular disease
Dongchao Lu et al.
NATURE REVIEWS CARDIOLOGY (2019)
MicroRNAs in Cardiac Hypertrophy
Nadine Wehbe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation
Shuai Song et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
Inhibition of Smurf2 translation by miR-322/503 protects from ischemia-reperfusion injury by modulating EZH2/Akt/GSK3β signaling
Wei Dong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
Mechanisms of physiological and pathological cardiac hypertrophy
Michinari Nakamura et al.
NATURE REVIEWS CARDIOLOGY (2018)
miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes
Martine Croset et al.
CANCER RESEARCH (2018)
MiRNA-based Therapeutics for Lung Cancer
Miaowei Wu et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure
Junjie Xiao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Regulation of Insulin Resistance by Multiple MiRNAs via Targeting the GLUT4 Signalling Pathway
Tong Zhou et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer
Di Chen et al.
CANCER LETTERS (2015)
miR-222 Is Necessary for Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling
Xiaojun Liu et al.
CELL METABOLISM (2015)
Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis A Translational Pilot Study
Yonathan F. Melman et al.
CIRCULATION (2015)
miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart
Bianca C. Bernardo et al.
FUTURE MEDICINAL CHEMISTRY (2015)
EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis
Pingyu Zhang et al.
JOURNAL OF PATHOLOGY (2014)
MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy
X. Li et al.
CELL DEATH & DISEASE (2014)
Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2
Anika Tschirner et al.
ESC HEART FAILURE (2014)
Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes
Shugo Tohyama et al.
CELL STEM CELL (2013)
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Hui Ling et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer
S-F Su et al.
ONCOGENE (2013)
MicroRNA-30d Induces Insulin Transcription Factor MafA and Insulin Production by Targeting Mitogen-activated Protein 4 Kinase 4 (MAP4K4) in Pancreatic β-Cells
Xiaomin Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study
Lei Kong et al.
ACTA DIABETOLOGICA (2011)
CaMKII Negatively Regulates Calcineurin-NFAT Signaling in Cardiac Myocytes
Scott M. MacDonnell et al.
CIRCULATION RESEARCH (2009)
Identification of glucose-regulated miRNAs from pancreatic β cells reveals a role for miR-30d in insulin transcription
Xiaoqing Tang et al.
RNA (2009)
Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy
BJ Wilkins et al.
CIRCULATION RESEARCH (2004)
Calcineurin and beyond - Cardiac hypertrophic signaling
JD Molkentin
CIRCULATION RESEARCH (2000)